Andrzej Szczeklik | Academic Influence

Andrzej Szczeklik's AcademicInfluence.com Rankings

Andrzej Szczeklik

Philosophy

#4391

World Rank

#6885

Historical Rank

Logic

#2170

World Rank

#3101

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Andrzej Szczeklik Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Andrzej Szczeklik was a Polish immunologist working at the Jagiellonian University School of Medicine in Kraków. Having received numerous distinctions for his research, Szczeklik was also well known as a writer.

(See a Problem?)

Andrzej Szczeklik's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International Consensus Report on Diagnosis and Treatment of Asthma. (1992) (685)
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. (1998) (554)
Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. (2003) (511)
Natural history of aspirin‐induced asthma (2000) (500)
Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. (1975) (456)
Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti‐inflammatory drugs (2013) (399)
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. (1998) (395)
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity (2007) (390)
Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA # and GA2LEN/HANNA * (2011) (375)
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. (1977) (340)
Clinical and pathologic perspectives on aspirin sensitivity and asthma. (2006) (332)
Aspirin-induced asthma: advances in pathogenesis and management. (1999) (331)
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. (2002) (323)
SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLIN (1979) (283)
Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation (2001) (251)
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. (2012) (224)
Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. (2001) (222)
Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. (2000) (207)
Leukotriene C 4 synthase promoter polymorphism and risk of aspirin-induced asthma (1997) (204)
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. (2001) (201)
Safety of a specific COX‐2 inhibitor in aspirin‐induced asthma (2001) (196)
Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. (2000) (195)
Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. (2004) (192)
Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. (1996) (191)
The cyclooxygenase theory of aspirin-induced asthma. (1990) (188)
Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. (1978) (186)
Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. (2000) (174)
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism (2003) (172)
Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. (2000) (171)
PlA2 Polymorphism of &bgr;3 Integrins Is Associated With Enhanced Thrombin Generation and Impaired Antithrombotic Action of Aspirin at the Site of Microvascular Injury (2001) (162)
A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. (2003) (159)
Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. (1994) (159)
Homocysteine and thrombosis: from basic science to clinical evidence (2005) (156)
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. (2004) (154)
Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. (2003) (150)
Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. (1993) (148)
Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. (1999) (144)
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. (1998) (144)
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls (2013) (138)
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease (2006) (135)
Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa (2000) (133)
Thromboxane Generation and Platelet Aggregation in Survivals of Myocardial Infarction (1978) (130)
Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland (2003) (129)
Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. (2003) (128)
The presence of rhinovirus in lower airways of patients with bronchial asthma. (2008) (127)
Aspirin‐induced asthma as a viral disease (1988) (127)
Plasma Homocysteine Affects Fibrin Clot Permeability and Resistance to Lysis in Human Subjects (2006) (119)
The broken balance in aspirin hypersensitivity. (2006) (117)
Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. (2001) (117)
Dietary Supplementation with Vitamin E in Hyperlipoproteinemias: Effects on Plasma Lipid Peroxides, Antioxidant Activity, Prostacyclin Generation and Platelet Aggregability (1985) (117)
Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. (2014) (113)
Antiplatelet drugs and generation of thrombin in clotting blood. (1992) (110)
Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. (1997) (110)
Important research questions in allergy and related diseases: 3‐chronic rhinosinusitis and nasal polyposis – a GA2LEN study (2009) (107)
Plasma 9α,11β-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma (2004) (107)
The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine. (1987) (106)
Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. (2003) (105)
Allergic Rhinitis and its Impact on Asthma (ARIA): In collaboration with the World Health Organization (2002) (104)
Mechanism of aspirin‐induced asthma (1997) (104)
Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. (1996) (103)
The atopy trait in hypersensitivity to nonsteroidal anti‐inflammatory drugs (1996) (100)
Mechanisms of virus‐induced asthma exacerbations: state‐of‐the‐art. A GA2LEN and InterAirways document (2007) (99)
Treatment of steroid-dependent bronchial asthma with cyclosporin. (1995) (95)
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. (2001) (91)
Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. (1980) (91)
Clinical features and diagnosis of aspirin induced asthma (2000) (91)
Pathogenesis of Vascular Disease in Hyperhomocysteinaemia (1998) (91)
Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man (1978) (90)
Prolonged Bleeding Time, Reduced Platelet Aggregation, Altered PAF-Acether Sensitivity and Increased Platelet Mass Are a Trait of Asthma and Hay Fever (1986) (90)
Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients. (2012) (89)
Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation (1999) (89)
Humoral immunosuppression in men exposed to polycyclic aromatic hydrocarbons and related carcinogens in polluted environments. (1994) (87)
Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia. (2001) (87)
Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia (2005) (86)
Aspirin intolerance and the cyclooxygenase-leukotriene pathways. (2004) (85)
Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. (2014) (83)
Anti-platelet action of intravenous infusion of prostacyclin in man. (1978) (83)
Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. (1997) (79)
[Aspirin-induced asthma]. (1976) (75)
Haemodynamic changes induced by prostacyclin in man. (1980) (73)
Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia. (1996) (72)
Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin‐induced asthma (1997) (70)
Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. (1987) (69)
Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects. (2010) (68)
Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine. (1979) (68)
Prevalence of COPD and tobacco smoking in Malopolska region--results from the BOLD study in Poland. (2007) (68)
Hypersensitivity to Aspirin and Non-Steroidal Antiinflammatory Drugs (2009) (68)
Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity (2007) (68)
Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. (1981) (66)
Idiosyncrasy to Pyrazolone Drugs (1981) (66)
Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome. (2011) (65)
Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease. (1986) (65)
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis (2006) (64)
Antibodies to N-homocysteinylated albumin as a marker for earlyonset coronary artery disease in men (2005) (63)
Serum immunoglobulin E response to myocardial infarction. (1988) (63)
Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype. (2011) (62)
Analgesics, allergy and asthma. (1980) (62)
Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. (2009) (61)
Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease (2002) (61)
Leukotriene C4 synthase polymorphism and aspirin-induced asthma. (2001) (61)
Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist (2002) (60)
Prostacyclin therapy in peripheral arterial disease. (1980) (60)
Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. (1995) (59)
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project (2009) (57)
Eosinophilic fasciitis successfully treated with cyclosporine (2005) (56)
Eoxins: a new inflammatory pathway in childhood asthma. (2010) (55)
Hydrocortisone and airflow impairment in aspirin-induced asthma. (1985) (55)
Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled study. (1985) (54)
A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma (2000) (54)
Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients. (2005) (53)
Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis (2003) (53)
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients (2004) (53)
Persistent generation of thrombin after acute myocardial infarction. (1992) (53)
The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. (2005) (52)
Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma. (2005) (51)
Prostacyclin for acute coronary insufficiency. (1980) (49)
Familial aggregation of aspirin‐induced urticaria and leukotriene C4 synthase allelic variant (2006) (49)
The α‐chain of high‐affinity receptor for IgE (FcɛRIα) gene polymorphisms and serum IgE levels (2006) (49)
Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. (1999) (48)
The use of endobronchial ultrasonography in assessment of bronchial wall remodeling in patients with asthma. (2009) (48)
Cyclosporin for steroid‐dependent asthma (1991) (47)
Aspirin-induced rhinitis and asthma (2001) (47)
Genetic mechanisms in aspirin-induced asthma. (2000) (46)
PROSTACYCLIN FOR PULMONARY HYPERTENSION (1980) (45)
Two Different Transcription Factors Discriminate the −315C>T Polymorphism of the FcεRIα Gene: Binding of Sp1 to −315C and of a High Mobility Group-Related Molecule to −315T1 (2008) (44)
Glucocorticosteroids attenuate aspirin-precipitated adverse reactions in aspirin-intolerant patients with asthma. (1989) (44)
Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial. (2003) (43)
Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. (1998) (41)
Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study (2004) (41)
Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication. (2013) (39)
Eicosanoids in exhaled breath condensates in the assessment of childhood asthma (2008) (39)
Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps. (1977) (39)
Heterogeneity of serum γ-glutamyl transpeptidase in hepatobiliary diseases (1967) (38)
Intolerance to tartrazine in aspirin-induced asthma: results of a multicenter study. (1988) (38)
Nasal versus bronchial and nasal response to oral aspirin challenge: Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. (2003) (37)
PROSTAGLANDINS AND ASPIRIN-INDUCED ASTHMA (1976) (37)
Testing for aspirin hypersensitivity (2002) (37)
Morphine antagonises prostaglandin E1- mediated inhibition of human platelet aggregation (1975) (37)
Genetics of aspirin induced asthma (2000) (36)
The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin (2007) (36)
Hyperhomocysteinemia following oral methionine load is associated with increased lipid peroxidation. (1997) (36)
The role of COX‐1 and COX‐2 in asthma pathogenesis and its significance in the use of selective inhibitors (2002) (36)
Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases (2007) (35)
The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease. (2010) (35)
Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man. (1979) (34)
Treatment with Simvastatin and Low-dose Aspirin Depresses Thrombin Generation in Patients with Coronary Heart Disease and Borderline-high Cholesterol Levels (2001) (34)
Effects of Cyclooxygenases Inhibitors on Vasoactive Prostanoids and Thrombin Generation at the Site of Microvascular Injury in Healthy Men (2003) (34)
Value of transthoracic echocardiography for the detection of high-grade coronary artery stenosis: prospective evaluation in 50 consecutive patients scheduled for coronary angiography. (2000) (34)
Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome. (2009) (33)
Prostacyclin and the fibrinolytic system in ischemic vascular disease. (1983) (33)
Protection against exercise‐induced bronchoconstriction by montelukast in aspirin‐sensitive and aspirin‐tolerant patients with asthma (2002) (33)
Nitric Oxide Production and Endothelium-Dependent Vasorelaxation Ameliorated by N 1-Methylnicotinamide in Human Blood Vessels (2012) (32)
Long-term effects of thoracic sympathectomy on microcirculation in the hands of patients with primary Raynaud disease. (2007) (32)
Asthma relieved by aspirin and by other cyclo-oxygenase inhibitors. (1978) (32)
Mechanism of chronic urticaria exacerbation by aspirin (2005) (31)
Altered distribution of IgG subclasses in aspirin‐induced asthma: high IgG4, low IgG1 (1992) (31)
The Course of Asthma in Churg–Strauss Syndrome (2011) (31)
Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screening. (2007) (30)
Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study (2012) (29)
Interferon‐gamma in the treatment of atopic dermatitis: influence on T‐cell activation (1995) (29)
Psychopathology and Personality Factors Modify the Perception of Dyspnea in Asthmatics (2007) (29)
The prevalence of alpha(1)-antitrypsin deficiency in a representative population sample from Poland. (2007) (29)
Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy (2006) (29)
Blood fibrinolytic activity, social class and habitual physical activity--II. A study of black and white men in Southern Georgia. (1980) (29)
Bronchial reactivity to prostaglandins F2alpha, E2, and histamine in different types of asthma. (1977) (29)
Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations. (1976) (29)
Asthmatic attacks induced in aspirin-sensitive patients by diclofenac and naproxen. (1977) (28)
A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day). (2000) (28)
Eicosanoids, Aspirin, and Asthma (1998) (27)
Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics. (2007) (27)
Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria. (2006) (27)
Choline magnesium trisalicylate in patients with aspirin-induced asthma. (1990) (27)
Correlation between airborne pollen incidence, skin prick tests and serum immunoglobulins in allergic people in cracowm, poland (1991) (26)
Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma (2015) (26)
Thrombin Generation Measured Ex Vivo Following Microvasculor Injury Is Increased in SLE Patients with Antiphospholipid-protein Antibodies (1997) (26)
Exercise training in intermittent claudication: Effects on antioxidant genes, inflammatory mediators and proangiogenic progenitor cells (2012) (26)
Anti-thrombotic action of clopidogrel and PlA1/A2 polymorphism of β3 integrin in patients with coronary artery disease not being treated with aspirin (2005) (26)
Comparison of the Effect of Verapamil and Propranolol on Response of Coronary Vasomotion to Cold Pressor Test in Symptomatic Patients with Hypertrophic Cardiomyopathy (2000) (25)
Prostaglandin E2 and aspirin-induced asthma (1995) (25)
Delayed generation of thrombin in clotting blood of atopic patients with hayfever and asthma (1991) (25)
Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction (1993) (25)
Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease. (2007) (25)
MYOCARDIAL INFARCTION IN STATUS ASTHMATICUS (1977) (24)
Assessment of Airway Caliber in Quantitative Videobronchoscopy (2006) (24)
Both Th 2 and Th 17 responses are involved in the pathogenesis of Churg-Strauss syndrome (2006) (24)
Elevated urinary leukotriene E4 excretion in asthma: a comparison of HPLC‐mass spectrometry and ELISA (2010) (23)
Towards a multidisciplinary and integrated strategy in the assessment of adverse health effects related to air pollution: the case study of Cracow (Poland) and asthma. (2006) (23)
Immunoglobulin E in acute phase response to surgical stress (1996) (23)
Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury (2006) (22)
Genetic polymorphisms of the novel FCERIA gene region: relation to total serum IgE levels. (2007) (22)
12‐hydroxy‐eicosatetraenoic acid (12‐HETE): a biomarker of Churg‐Strauss syndrome (2012) (21)
Myocardial ischemia possibly mediated by cysteinyl leukotrienes. (2002) (21)
Asthma improved by aspirin-like drugs. (1983) (21)
Additive association between FCER1A and FCER1B genetic polymorphisms and total serum IgE levels (2007) (21)
Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy (2000) (21)
Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor. (1994) (21)
Inhibition by Ketotifen of Idiosyncratic Reactions to Aspirin (1980) (20)
Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children. (2011) (20)
Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma. (1987) (20)
Antithrombotic actions of statins. (2001) (19)
The effects of prostacyclin on glycemia and insulin release in man. (1980) (19)
Molecular Mechanisms in Aspirin-Induced Asthma (2000) (19)
Two different transcription factors discriminate the -315C>T polymorphism of the Fc epsilon RI alpha gene: binding of Sp1 to -315C and of a high mobility group-related molecule to -315T. (2008) (19)
Asthma and anti-inflammatory drugs. Mechanisms and clinical patterns. (1983) (18)
Aspirin-induced asthma: a tribute to John Vane as a source of inspiration. (2010) (18)
Verapamil Improves the Response of Coronary Vasomotion to Cold Pressor Test in Asymptomatic and Mildly Symptomatic Patients with Hypertrophic Cardiomyopathy (1999) (18)
Genetic polymorphisms in chronic obstructive pulmonary disease. (2005) (18)
Catharsis: On the Art of Medicine (2005) (17)
The value of pollen count for diagnosis and therapy of pollen allergy in Poland (1990) (17)
Genetic variability of the high-affinity IgE receptor α-subunit (FcεRIα) (2009) (17)
Alternation in both insulin release and its hypoglycemic effects in atopic bronchial asthma. (1980) (17)
Serum interleukin‐5 in aspirin‐induced asthma (2001) (16)
Aspirin Sensitivity: Other Drugs (1975) (16)
The mechanism of anti-thrombotic, thrombolytic and fibrinolytic actions of camonagrel--a new thromboxane synthase inhibitor. (1995) (16)
Efficacy of physical therapy methods in airway clearance in patients with chronic obstructive pulmonary disease: a critical review. (2010) (16)
An abnormality of arachidonic acid metabolism is not a generalized phenomenon in patients with aspirin-induced asthma. (1988) (16)
Analgesics and asthma. (2002) (16)
Cardiopulmonary function in 1 -antitrypsin heterozygotes exposed to severe air pollution. (1973) (15)
Aspirin-Sensitive Asthma: Its Relationship to Inhibition of Prostaglandin Biosynthesis (1977) (15)
High-Resolution Computed Tomography Evaluation of Peripheral Airways in Asthma Patients: Comparison of Focal and Diffuse Air Trapping (2008) (15)
Thrombin Generation in Myocardial Infarction and Hypercholesterolemia: Effects of Aspirin (1995) (15)
Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis. (2002) (15)
Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status (2002) (15)
Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma. (2007) (14)
Mild Asthmatics Benefit from Music Therapy (2012) (14)
Gender gap in psychogenic factors may affect perception of asthma symptoms. (2011) (14)
Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens (2012) (14)
Functional promoter polymorphism of cyclooxygenase-2 modulates the inflammatory response in stable coronary heart disease. (2010) (14)
Serum peptidases in myocardial infarction. (1972) (14)
CLINICAL COURSE OF ASPIRIN-INDUCED ASTHMA : RESULTS OF AIANE (1998) (14)
Hemodynamic effects of prostacyclin in man. (1980) (13)
Prostaglandins and aspirin-sensitive asthma. (2015) (13)
Antipyretic analgesics and the allergic patient. (1983) (13)
Reasons for resistance to aspirin in cardiovascular disease. (2002) (13)
Prostacyclin for unstable angina. (1980) (13)
PATHOPHYSIOLOGY AND PHARMACOLOGY OF ASPIRIN-INDUCED ASTHMA (1991) (13)
Inhibition of prostacyclin formation by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis. (1978) (13)
Plasma fibrinolytic activity in healthy subjects with high and low lipoprotein(a) concentrations. (1992) (13)
Thrombin Generation Markers and Coronary Heart Disease Risk Factors in a Polish Population Sample (1997) (13)
Ketotifen versus sodium cromoglycate in the therapy of allergic (extrinsic) bronchial asthma. (1980) (13)
Aspirin-induced asthma: an update and novel findings. (1994) (13)
Pharmacological Agents in Bronchial Provocation Tests (1993) (13)
[The frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire]. (2009) (12)
Lack of effect of i.v. prostacyclin on aspirin-induced asthma. (1986) (12)
Transthoracic, harmonic mode, contrast enhanced color Doppler echocardiography in detection of restenosis after percutaneous coronary interventions. Prospective evaluation verified by coronary angiography. (2004) (12)
Aspirin delays thrombin generation in vitro through interaction with platelet phospholipids. (1997) (12)
Arachidonate Versus ADP-Induced Platelet Aggregation in Acute Myocardial Infarction (1979) (12)
Anti-cyclo-oxygenase agents and asthma. (1983) (12)
Central Dopamine Receptors Regulate Blood Eosinophilia in the Rat (1979) (12)
Autoimmune vasculitis and aortic stenosis in aspirin‐induced asthma (AIA) (1997) (12)
Factor XIII Val34Leu polymorphism and γ‐chain cross‐linking at the site of microvascular injury in healthy and coumadin‐treated subjects (2005) (12)
Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy (2005) (12)
Atopy and sudden cardiac death (2000) (12)
Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria (2004) (11)
Platelet glycoprotein IIIa pl(a) polymorphism and effects of aspirin on thrombin generation. (2001) (11)
Cyclosporin for a severe case of aspirin-induced asthma. (1991) (11)
Aspirin-induced asthma: pathogenesis and clinical presentation. (1992) (11)
Hypersensitivity to Aspirin and Other NSAIDs: Mechanisms, Clinical Presentation and Management (2007) (11)
Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease (2008) (11)
FCERIA gene promoter polymorphisms: lack of association with aspirin hypersensitivity in whites. (2007) (11)
Incides of lipid peroxidation in patients with hypercholesterolemia and hypertriglyceridemia. (1989) (11)
Bleeding time and PAF-acether-induced platelet aggregation in atopy. (1987) (11)
Salicylate pre‐treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin‐intolerant patients (1990) (11)
PROSTACYCLIN, NITROGLYCERIN, AND EFFORT ANGINA (1981) (11)
Autoimmune vasculitis preceding aspirin-induced asthma. (1995) (11)
Dihomo-γ-Linolenic Acid in Patients with Atherosclerosis: Effects on Platelet Aggregation, Plasma Lipids and Low-Density Lipoprotein-Induced Inhibition of Prostacyclin Generation-Reply (1984) (11)
Serum alpha 1-antitrypsin in bronchial asthma. (1974) (11)
Genetic Variability of the High-affinity IgE Receptor α Subunit (Fc ε RI α) is Related to Total Serum IgE levels in Allergic Subjects. (2007) (10)
[Nonallergic rhinitis with eosinophilia syndrome: state of knowledge]. (2003) (10)
Impaired Response of the Forearm Resistance but not Conductance Vessels to Reactive Hyperemia in Hypertrophic Cardiomyopathy (1999) (10)
Prostaglandins in therapy of cardiovascular disease. (1985) (10)
Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy. (2002) (10)
Association between inflammatory markers and the interleukin-6 -174 G/C polymorphism is abolished in peripheral arterial occlusive disease. (2007) (10)
Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease. (1978) (10)
Effects of prostacyclin and its stable analog, iloprost, upon insulin secretion in isolated pancreatic islets. (1984) (10)
Cyclosporin and asthma (1992) (10)
Prostacyclin and atherosclerosis. (1980) (9)
Hypersensitivity to Aspirin and other NSAIDs (2009) (9)
Possible role of IgE in acute‐phase response (1997) (9)
Aspirin-induced asthma: from pathogenesis to therapy. (1993) (9)
Aspirin-induced asthma: new insights into pathogenesis and clinical presentation of drug intolerance. (1989) (9)
The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease (2005) (9)
Pharmacological inhibition of leukotriene biosynthesis: effects on the heart conductance. (2010) (9)
Mechanisms responsible for reducing intermittent claudication as a result of treadmill training (2010) (8)
Bronchodilatory properties of 2-decarboxy-2-hydroxymethyl prostaglandin E1. (1985) (8)
MECHANISMS OF ASPIRIN-INDUCED ASTHMA (1998) (8)
Dyspnea is Related to Family Functioning in Adult Asthmatics (2009) (8)
FCER1A gene exon 1A polymorphisms in Japanese and Polish subjects – a comparative analysis of haplotypes (2008) (8)
Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation. (2010) (8)
Possible Relationship between Interleukin‐6 and Response of Immunoglobulin E to Surgical Trauma (1995) (8)
Mast cell activation after adenosine inhalation challenge in patients with bronchial asthma (2007) (7)
Inhibition of Thrombin Generation by Aspirin (1994) (7)
Non-steroidal anti-inflammatory drugs (NSAID) sensitivity in chronic idiopathic urticaria (CIU): Selective involvement of cyclooxygenase 1 (COX-1) and overproduction of cysteinyl-leukotrienes (cys-LTs)* (2003) (7)
Anti-interleukin-5 therapy and severe asthma. (2009) (7)
Generation of the proteolytic activity bound with α2-macroglobulin during plasma clotting (1970) (7)
Montelukast for persistent asthma (2001) (7)
Cobalt-activated acylase in human serum. Occurrence in hepatobiliary diseases. (1971) (7)
Analgesics and Nonsteroidal Anti-Inflammatory Drugs (1983) (7)
[Links between panic disorder, depression, defence mechanisms, coherence and family functioning in patients suffering from severe asthma]. (2006) (7)
Aspirin and thrombinogenesis. (2003) (7)
Heterogeneity of serum gamma-glutamyl transpeptidase in hepatobiliary diseases. (1967) (7)
Interleukin-6 −174 G/C promoter polymorphism and effects of fenofibrate and simvastatin on inflammatory markers in hypercholesterolemic patients (2006) (6)
Locus of control and selected mental health variables in asthmatics: what are the associations with dyspnea? (2011) (6)
FCER1A gene proximal promoter polymorphisms in Caucasians and East Asians (2008) (6)
Participation of prostaglandins in pathogenesis of aspirin-sensitive asthma (2004) (6)
Gamma interferon administration to patients with atopic dermatitis inhibits fibrinolysis and elevates C1 inhibitor. (1998) (6)
CYCLO-OXYGENASE. AUTHOR'S REPLY (1998) (6)
Sulfinpyrazone and aspirin-induced asthma. (1980) (6)
Novel exon 2A of the high-affinity receptor for the IgE alpha-chain gene (FCER1A) and autoimmunity in patients with asthma or urticaria. (2006) (6)
Ex Vivo Thrombin Generation in Patients With Venous Thromboembolic Disease or Atrial Fibrillation on Long-Term Oral Anticoagulation (2010) (6)
Interaction of functional FCER2 promoter polymorphism and phenotype-associated haplotypes. (2009) (6)
Cardiovascular Actions of Prostacyclin in Man (1981) (5)
[Multicenter controlled trial of desensitization treatment of pollen-induced hay fever and asthma with pollinex vaccine]. (1979) (5)
Generation of the proteolytic activity bound with alpha 2-macroglobulin during plasma clotting. (1970) (5)
The effect of prostacyclin on asthma precipitated by aspirin. (1987) (5)
[The effect of music therapy on anxiety level in hospitalized asthmatic patients]. (2005) (5)
[Value of Monitoring Serum Immunoglobulins Questioned]: Response (1994) (5)
Molecular diagnostics of α1-antitrypsin deficiency. (2007) (5)
Hypersensitivity to systemic corticosteroids in aspirin-sensitive patients with asthma. (2011) (5)
Central Regulation of Blood Eosinophilia by the β-Adrenergic System in Rats (1976) (5)
Aspirin, prostaglandins, and bronchial asthma. (1980) (4)
Treatment with prostacyclin of various forms of spontaneous angina pectoris not responding to placebo. (1984) (4)
Increase in plasma sCD23 levels precedes immunoglobulin E elevation after coronary artery bypass graft surgery. (2011) (4)
[Advanced abdominal angina due to atherosclerosis with atypical celiac arteries]. (2000) (4)
Genetic associations of variants of the high affinity receptor for immunoglobulin E in Wegener's granulomatosis. (2009) (4)
Standards of nasal provocation tests (2010) (4)
Inhibition of idiosyncratic reactions to aspirin by ketotifen. (1980) (4)
Aspirin and asthma. (1982) (4)
Origin of aspirin-induced asthma. (1989) (4)
Trypsin-like activity of serum: its origin and electrophoretic separation. (1969) (4)
Prostacyclin and vascular disease. (1981) (4)
[No objections against solosine in acetylsalicylic acid sensitive asthma patients]. (1979) (4)
Effects of prostanoids on generation of superoxide ions by human neutrophils. (1987) (4)
[Clinical variability in two cases of systemic mastocytosis]. (2001) (4)
[Links between panic disorder, depression, defence mechanisms, coherence and family functioning in patients suffering from severe COPD]. (2008) (4)
Serum immunoglobulin E after myocardial infarction. (1989) (4)
Treatment with interferon gamma enhances fibrinolysis in systemic sclerosis. (1998) (3)
[Cholestatic hepatitis as a ticlopidine-induced complication of treatment - a case report]. (2008) (3)
Proteolytic activity of serum bound with alpha 2-macroglobulin in diseases with reduced thrombin formation in clotting blood. (1971) (3)
Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib (2005) (3)
Inhibitory effect of clot on proteolytic activity of serum bound with alpha-2-macroglobulin. (1969) (3)
Thrombin formation in platelet-rich plasma after oral methionine loading: preliminary report. (2002) (3)
Rhinovirus Infection in Lower Airways of Asthmatic Patients (2006) (3)
The Effect of Verapamil on Response of Coronary Vasomotion to Handgrip Exercise in Symptomatic Patients with Hypertrophic Cardiomyopathy (2001) (3)
DOUBLE AORTIC ARCH ASSOCIATED WITH PERICENTRIC INVERSION OF CHROMOSOME 9 (1997) (3)
Lepkość krwi w chorobach układu krążenia ze szczególnym uwzględnieniem kardiologicznego zespołu X Blood viscosity in cardiac syndrome X and other cardiovascular disorders (2005) (3)
Aspirin sensitive asthma and arachidonic acid transformation. (1986) (3)
[Humoral immune response to tissue injury, characterized by a rise in serum immunoglobulin E]. (1995) (3)
Reactive Oxygen Species Metabolism and Allergy (2006) (3)
[Thrombotic thrombocytopenic purpura with myocardial ischaemia: two case reports]. (2008) (3)
Mediator assays in aspirin-induced asthma. (1994) (3)
Glycyl peptidase in human serum and tissues (1969) (3)
Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications (2004) (3)
[Levels of carnitine and homocysteine in plasma of long-term hemodialysis patients with chronic renal failure]. (2001) (3)
Thrombinogenesis and its pharmacological modulation in atherosclerosis. (1994) (3)
Serum cobalt-activated acylase and gamma-glutamyl transpeptidase activities in toxic hepatitis. (1975) (3)
Analgesics, Allergy and Asthma (2012) (3)
Adaptive mechanisms counterbalancing enhanced thrombinogenesis in antiphospholipid syndrome. (1998) (3)
The I Allele of the Angiotensin-Converting Enzyme Gene Polymorphism may Determine an Increase in Homocysteine Levels in Fibrate-Treated Subjects (2006) (3)
Interleukin-6 (IL-6)-174 G/C polymorphism--lack of association with inflammatory and haemostatic variables in patients with coronary heart disease treated with atorvastatin and quinapril. (2006) (3)
Aspirin, Related Nonsteroidal Anti-Inflammatory Agents, Sulfites, and Other Food Additives as Precipitating Factors in Asthma (1994) (3)
THE HISTORY OF ASPIRIN : THE DISCOVERIES THAT CHANGED CONTEMPORARY MEDICINE (2013) (2)
Prostacyclin in the treatment of atherosclerosis obliterans and other vascular diseases. (1984) (2)
Haemodynamic and antihypertensive effect of prostacyclin. (1984) (2)
[Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome]. (2008) (2)
Endovascular treatment of severe lower leg ischemia in patients not suitable for open surgery (2007) (2)
[Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)]. (1980) (2)
Lipid peroxidation, vitamin E, and cardiovascular disease. (1992) (2)
[Prostaglandin D2: biosynthesis, biological properties and participation in bronchial asthma]. (2001) (2)
The Activity of Plasma, Serum, Thrombin, and Plasmin toward Synthetic Trypsin Substrates (1968) (2)
[Difficult asthma and gender of patients versus the presence of profound psychological trauma]. (2006) (2)
Coding region for the high affinity receptor of immunoglobulin E is highly conservative in allergic patients (2007) (2)
[Acute respiratory distress syndrome (ARDS)]. (2000) (2)
[Simplified method of determination of blood acylase activity as a new test for preclinical diagnosis of viral hepatitis]. (1974) (2)
[Human recombinant interferon gamma in the treatment of atopic dermatitis]. (1994) (2)
Serum peptidases in myocardial infarction 233 TABLE Activity of serum peptidases in 38 patients with myocardial infarction (2)
[Coincidence of 20210A prothrombin variant and factor V Leiden predisposing to venous thromboembolism]. (1999) (2)
Reasons for aspirin resistance (2011) (2)
Mast Cell, IgE and Atherothrombosis (1998) (2)
Aspirin resistance (2005) (2)
Genetic variability of the high-affinity IgE receptor alpha subunit (Fc epsilon RI alpha) is related to total serum IgE levels in allergic subjects. (2007) (2)
Blood coagulation at the site of microvascular injury in healthy and coumadin-treated subjects heterogenous for factor V Leiden mutation (2007) (2)
Asthma and nonsteroidal anti-inflammatory drugs. (1979) (2)
[Polymorphic clinical picture in a case of osteomyelosclerosis]. (1965) (2)
[Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis]. (2002) (2)
Aspirin resistance. (2005) (2)
Eicosanoids and aspirin-sensitive asthma. (1987) (2)
Novel polymorphic short tandem repeat in the human alpha2 integrin gene promoter is associated with GPIa/IIa density on the platelet surface (2003) (1)
[Lipid peroxides and antioxidants in the plasma of healthy persons and in patients with arteriosclerosis]. (1986) (1)
Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children. (2014) (1)
[Alpha-1-antitrypsin and antithrombin 3 deficiency in a case of pulmonary emphysema]. (1971) (1)
Activity of serum aminopeptidases in diseases of the liver and bile ducts. (1967) (1)
Antioxidant effects of vitamin E in hyperlipoproteinemias (1987) (1)
More on: aspirin resistance (2004) (1)
Anti-Platelet and Vasodilatory Action of Prostacyclin /PGI2/ in Healthy Men and in Patients with Peripheral Artery Disease (1979) (1)
[High levels of cholesterol and lipoprotein (A) in serum decreases the inhibitory effect of aspirin on generation of thrombin]. (1995) (1)
[Prevalence of thrombosis in secondary antiphospholipid-protein syndrome]. (1996) (1)
[Alpha-1 antitrypsin level and phenotype Pi in healthy subjects and patients with asthma]. (1974) (1)
Atrioventricular block in hyperthyroidism. (1971) (1)
216 The effect of diflunisal on pulmonary function in aspirin-sensitive asthma (1985) (1)
[Serum proteolytic activity connected with alfa 2 macroglobulin in hemorrhagic diathesis]. (1971) (1)
Aspirin-Sensitive Asthma (2009) (1)
[Serum alpha 1 antitrypsin in healthy subjects and in patients with pulmonary emphysema]. (1973) (1)
More on Catharsis (2006) (1)
Tolerance of azapropazone: allergic and pseudo-allergic reactions and comparison with other NSAIDs (1989) (1)
Nasal Polyps and Lower Respiratory Tract Relationship (2010) (1)
Physiotherapy interventions in the BTS guidelines on the management of asthma (2011): a need for change? (2011) (1)
[Polyunsaturated fatty acids in the prevention of arteriosclerosis]. (1984) (1)
[Laboratory diagnosis of lupus anticoagulant]. (1996) (1)
Cyclosporin and asthma. (1992) (1)
Prostacyclin in the therapy of peripheral arterial disease. (1980) (1)
17 – Platelets and Ischemic Heart Disease (1985) (1)
[Puerperal cardiomyopathy--a report of 2 cases]. (1974) (1)
[Severe COPD and gender of patients versus the presence of profound psychological trauma]. (2008) (1)
[Diagnostic value of determination of cobalt-activated acylase in acute and chronic hepatitis]. (1973) (1)
Immunological status of patients with recurrent chest infections (1978) (1)
[Familial hyperhomocysteinemia with early development of atherosclerosis]. (1996) (1)
Effect of indomethacin on pulmonary vasomotor response in patients with mitral stenosis. (1977) (1)
[The role of leucotrienes in coronary artery disease and new therapy perspectives]. (2011) (1)
[Tolerability of Asacard--controlled-release aspirin and aspirin-induced asthma]. (2002) (1)
Serum proteolytic activity bound with alpha2-macroglobulin in hepato-biliary diseases. (1970) (1)
Asthma and Anti-inflammatory Drugs (1983) (1)
Cholestatyczne zapalenie wątroby jako powikłanie leczenia tiklopidyną - opis przypadku Cholestatic hepatitis as a ticlopidine-induced complication of treatment - a case report (2008) (1)
[Prostaglandin E2: metabolism, determination in body fluids and the role in aspirin hypersensitivity]. (2006) (1)
1 IgG4-restricted response in aspirin-induced asthma (1991) (1)
DIHOMO-γ- Linolenic Acid in Patients with Atherosclerosis ; Effects on Platelets, Plasma Lipids and LDL-Induced Inhibition of Prostacyclin Generation (1983) (1)
Letter: Aspirin sensitivity: other drugs. (1975) (1)
[Allergic reactions to gypsum]. (1975) (1)
Clinical Use of Prostacyclin in Vascular Disease (1983) (1)
[Liver cirrhosis and dysimmunoglobulinemia in a patient with Pi M phenotype alpha 1-antitrypsin deficiency]. (1977) (1)
Dihomo-γ-Linolenic Acid in Patients with Atherosclerosis: Effects on Platelet Aggregation, Plasma Lipids and Low-Density Lipoprotein-Induced Inhibition of Prostacyclin Generation (1984) (1)
[New possibilities of treating acute angioedema caused by C1-inhibitor deficiency]. (1989) (1)
[Effectiveness of ofloxacin in the treatment of bacterial infections of the respiratory tract]. (1988) (0)
Cyclooxygenase-2 gene polymorphism G−765C and prostaglandin synthesis in patients with bronchial asthma (2004) (0)
The Pope's grievous errors. (2005) (0)
[Platelet aggregation in coronary disease]. (1979) (0)
Proteolytic activity of human blood leukocytes toward synthetic trypsin substrate. I. Method. (1969) (0)
Multiple forms of human serum gamma-flutamyl transpeptidase. (1967) (0)
Asthmarelieved byaspirin andbyother cyclo-oxygenase inhibitors (1978) (0)
[Late enzymatic test in myocardial infarction]. (1968) (0)
[Factor V leiden and venous thromboembolism in a woman taking second generation oral contraceptives: a case report]. (1999) (0)
2P-0617 Pleiotropic effects after a 3-day treatment with the lipid lowering drugs in patients with coronary artery disease (2003) (0)
2P-0385 Methionine loading affects thrombin generation in patients with coronary artery disease (2003) (0)
Introduction (2000) (0)
Bronchial fibroblasts from asthmatic patients have impaired biosynthesis of PGE2 under inflammatory condition (2003) (0)
[Recurrent hypoglycemia in a patient with liver cirrhosis]. (1966) (0)
[Distribution of cholesterol and triglycerides concentration in the blood serum of male population aged 40--59 years (author's transl)]. (1975) (0)
Evaluation of liver function during administration of nifenazone in rheumatic disease on the basis of serum protein studies and enzyme tests. (1972) (0)
[Behavior of seromucoid in the blood serum in early phases of myocardial infarction]. (1965) (0)
Two main biological effects of prostacyclin, i.e., its effect (1983) (0)
[Role of hypocalcemia in the development of uremic coma]. (1971) (0)
[Cobalt activated acylase in serum of patients poisoned with mushrooms]. (1976) (0)
[Intal in the treatment of allergic rhinitis]. (1976) (0)
[1st intravenous administration of prostacyclin to man]. (1978) (0)
[Effects of working conditions on risk factors of coronary disease]. (1973) (0)
The Pope's grievous errors (2005) (0)
Nasal provocation tests with lysine aspirin (2010) (0)
Targeted eicosanoid lipidomics of induced sputum as compared to exhaled breath condensate in asthmatics (2011) (0)
Platelets function in atopy with special reference to platelet-activating factor (1985) (0)
Identification of aspirin-induced asthma (AIA) subphenotypes using a clustering approach (2012) (0)
PROSTACYCLIN - CLINICAL IMPLICATIONS OF BIOLOGICAL ACTIONS1 (1980) (0)
[On the problem of the mechanism of conduction system disorders in myocardial infarct]. (1969) (0)
[Exhaled breath condensates analysis]. (2004) (0)
[Pulmonary edema in the course of arrhythmia as a problem of special care]. (1970) (0)
Impaired responses of growth hormone and blood eosinophils to L-dopa in atopy [proceedings]. (1978) (0)
Contents, Vol. 39, Supplement 1, 1980 (2004) (0)
Serumimmunoglobulin E responseto myocardial infarction (1988) (0)
[Ischemic ulcer in Madelung disease]. (2000) (0)
[Eosinophils: their structure, function and clinical evaluation]. (1976) (0)
Prostaglandins, prostacyclin and arteries. (1981) (0)
N1-methylnicotinamide improves endothelial dysfunction in human blood vessels: Direct evidence at a single cell level (2012) (0)
Determination of aminopeptidase A activity in the serum. (1968) (0)
[Polyunsaturated fatty acids and the development of neoplasm]. (1983) (0)
Leukotrienes and aspirin-intolerant asthma (1999) (0)
EICOSANOIDS IN INDUCED SPUTUM (IS) IN ASPIRIN-TOLERANT (ATA) AND ASPIRIN-INTOLERANT ASTHMATICS (AIA) (2006) (0)
2.P.370 Effect of simvastatin treatment on thrombin generation in marked hypercholesterolemia (1997) (0)
Evolution of aspirin hypersensitivity in allergic and non-allergic types of rhinitis (2005) (0)
[Influence of enzymatic induction on drug action (author's transl)]. (1973) (0)
[Diprophos in the treatment of asthma. Preliminary observations]. (1981) (0)
IgE-MEDIATED IMMUNOLOGICAL RESPONSE IN MYOCARDIAL INFARCTION (1987) (0)
[Selection of expectorants in the treatment of asthma and chronic bronchitis]. (1977) (0)
Dics-test for cobalt-activated acylase activity and its use for early diagnosis of viral hepatitis. (1977) (0)
[Disodium cromoglycate in the treatment of grass-pollen asthma]. (1973) (0)
[Bronchodilating effect of Berotec in bronchial asthma]. (1974) (0)
Role of leukotrienes in aspirin-induced asthma (1998) (0)
[Hyperreactivity of the bronchial tree in asthma]. (1977) (0)
[Prostoglandins and thromboxans in the regulation of bronchial function]. (1977) (0)
Amidase activity of human alpha-macroglobulin. (1973) (0)
S-5-5 Lipid Peroxidation , Vitamin E , and Cardiovascular Disease (2010) (0)
Eicosanoid mediators in distinct types of rhinitis (2003) (0)
553 EFFECTS OF TREADMILL TRAINING ON WALKING DISTANCE AND ENDOTHELIAL FUNCTION IN PATIENTS WITH INTERMITTENT CLAUDICATION (2011) (0)
Contents, Vol. 34, 1977 (1977) (0)
Central regulation of blood eosinophilia by the beta-adrenergic system in rats. (1976) (0)
[Intraalveolar hemorrhage as a cause of acute respiratory failure in catastrophic antiphospholipid syndrome]. (2001) (0)
[Netilmicin in the treatment of bacterial respiratory tract infections]. (1990) (0)
Serum Alpha1-Antitrypsin in Bronchial Asthma1 (2015) (0)
[May the Force be with antileukotriene drugs]. (2010) (0)
Treatment of cardiovascular disease with prostaglandins. (1984) (0)
[Value of the measurement of proteolytic activity of sputum for assessment of the effectiveness of health resort treatment]. (1979) (0)
[Activity of cobalt-activated acylase in liver tissue in patients with acute and chronic liver diseases]. (1977) (0)
[Air pollution caused by dust and the respiratory system. Long-term observations of workers in the Turow electric power station]. (1972) (0)
P3765 Association of asthma severity and quality of life in children (2005) (0)
Low Affinity Platelet Factor 4/β-Thromboglobulin (LA-PF4/βTG) Antigen And Circulating Platelet Aggregates During Prostacyclin (PGI2) Therapy (1981) (0)
[Tracheo-bronchial dyskinesia diagnosed as bronchial asthma]. (1980) (0)
Improvement of chronic care for patients with bronchial asthma with the use of teleinformatic tools (2006) (0)
[Alpha 1-antitrypsin deficiency in chronic liver disease]. (1977) (0)
[Prospects for controlling the biosynthesis of prostaglandins]. (1976) (0)
[Results of resuscitation in the department of internal diseases]. (1968) (0)
[Balloon angioplasty of branches of the aortic arch]. (1999) (0)
[Clinical and hemodynamic aspects of 2 cases of the cough-syncope syndrome]. (1983) (0)
4 Salicylate pretreatment attenuates intensity of symptoms precipitated by aspirin in aspirin-intolerant patients (1991) (0)
Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma. (1987) (0)
Comment to article Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes (2007) (0)
Key References: Markers of Platelet Activation (2000) (0)
[Functional disorders of the beta adrenergic system in atopic allergy]. (1978) (0)
[Lung cancer in patients with chronic obstructive lung disease]. (2005) (0)
Analgesics and asthma. (1973) (0)
[Bilateral bundle-branch block in myocardial infarct]. (1972) (0)
Faculty Opinions recommendation of Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. (2011) (0)
[Hemodynamic studies in myocardial infarct]. (1972) (0)
[The changes in risk factors level two years of implementation of the coronary disease prevention in Poland. II. The dynamics of changes in the risk group (author's transl)]. (1981) (0)
[New method of determination of salivary proteolytic activity using a synthetic trypsin substrate]. (1971) (0)
[Effect of radon on peripheral blood eosinophil count]. (1975) (0)
Abstract 12564: Nitric Oxide Production and Endothelium-dependent Vasorelaxation Induced by 1-methylnicotinamide in Human Blood Vessels (2010) (0)
[The value of glycine peptidase, leucine aminopeptidase and -glutamyl transpeptidase determinations in distant diagnosis of myocardial infarction]. (1972) (0)
[Value of histocytological examinations of the nasal mucosa in pollinosis]. (1987) (0)
148 Characteristic patterns of serum IgE and blood eosinophil count in myocardial infarction (1988) (0)
MS424 THE EFFECT OF PAIN-FREE TREADMILL TRAINING ON LEVELS OF LACTATE DEHYDROGENASE AND CREATINE KINASE IN PATIENTS WITH INTERMITTENT CLAUDICATION (2010) (0)
[Effect of vitamin E on the changes in plasma lipid peroxides and platelet aggregation in patients with hyperlipoproteinemia]. (1986) (0)
[Prostaglandins and lung function. III. Effect of prostaglandin E-2 on the bronchial tree in asthma]. (1978) (0)
[Pollen fallout and symptoms of hay fever]. (1985) (0)
MYOCARDIAL INFARCTION Serum immunoglobulin E response to myocardial infarction (0)
[Effect of prostacycline aerosol on the activity of blood platelets and lungs]. (1979) (0)
[Cobalt-activated acylase determination in serum as a new enzyme test in viral hepatitis]. (1972) (0)
IMPROVEMENT OF THIOLACTONASE ACTIVITY OF PARAOXONASE 1 BY SIMVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE (2007) (0)
Aspirin, prostaglandins and bronchial asthma [proceedings]. (1978) (0)
[Gastric acid secretion and serum pepsinogen levels in patients with asthma in the course of chronic corticosteroid therapy]. (1976) (0)
[Effect of dust on the state of health of workers of the Combinat Mining--Energetic Turów]. (1967) (0)
[Anti-inflammatory agents and aspirin-induced asthma]. (1979) (0)
[Effect of infection on the course of erythroleukemia]. (1968) (0)
[Diagnostic difficulties in cases of congenital hyperbilirubinemia]. (1974) (0)
Contents, Supplement 1, 1989 (1989) (0)
Treatment o of s steroid-dependent b bronchial a asthma with c cyclosporin (1995) (0)
[Enzymes of plasma and blood serum]. (1970) (0)
[Late shock in myocardial infarct]. (1969) (0)
[Spiral computed tomography in diagnosis of pulmonary embolism]. (1999) (0)
[The coexistence of hypercholesterolemia and other coronary disease risk factors (author's transl)]. (1977) (0)
[The methodological principles of the Polish trial of the primary prevention of ischaemic heart disease (author's transl)]. (1975) (0)
Hypersensitivity of Platelets to Arachidonate /AA/ in Acute Myocardial infarction /MI/ (1979) (0)
[Disorders of the cardiopulmonary function in heterozygotes with alpha 1 -antitrypsin deficiency]. (1973) (0)
[The menace of coronary disease in population of men in South Poland (author's transl)]. (1978) (0)
Montelukast for persistent asthma [3] (multiple letters) (2001) (0)
Chronic Aspirin Desensitization In Aspirin-Induced Asthma: Clinical Effects And Eicosanoid Response. A Double-Blind Study (2011) (0)
Influence of pain-free and traditional treadmill training on circulating endothelial progenitor cells, pro-angiogenic and pro-inflammatory cytokines in peripheral blood of intermittent claudication patients (2012) (0)
[Activity of certain serum aminopeptidases in shock]. (1967) (0)
Subject Index, Vol. 34, 1977 (1977) (0)
Comparative Study of Blood Fibrinolytic Activity and its Inhibitors in U.S. Blacks and Whites (1975) (0)
Asthma, aspirin and leukotrienes. (1983) (0)
[Clinical value of bromsulphalein test in early stage of myocardial infarct]. (1972) (0)
[Prostacyclins and myocardial infarct]. (1983) (0)
[Hypertension and other factors of coronary heart disease risk (author's transl)]. (1975) (0)
Immunoglobulin E response to coronary artery bypass graft in patients with or without perioperative myocardial infarction (1995) (0)
[Arrhythmia as a cause of sudden death in cardiac infarction]. (1969) (0)
[A case of "purpura fulminans" syndrome in an adult patient]. (1973) (0)
[Hemorrhagic thrombocythemia during treatment of asthma with triamcinolone acetonide]. (1981) (0)
[Metabolic disorders of alpha 1-antitrypsin in primary liver cancer]. (1978) (0)
Prostacyclin in vascular pathology--therapeutic possibilities. (1984) (0)
A novel molecular marker for endothelin - A receptor gene - lack of association between G1354C polymorphism and arterial disease in males (2004) (0)
[Lipoproteins (A) after a history of myocardial infarction, arteriosclerosis obliterans, hypertension and hyperlipidemia]. (1991) (0)
Prostacyclin in Therapy of Vascular Disease (1985) (0)
[Hyperhomocysteinemia and its relationship to atherosclerosis]. (1997) (0)
Eicosanoids in Induced Sputum (IS): Influence of Aspirin Hypersensitivity and Atopy (2006) (0)
[Spontaneous pneumomediastinum with subcutaneous emphysema and pneumothorax as the initial manifestation of bronchial asthma. Case report]. (2000) (0)
[Results of prolonged intal therapy in patients with bronchial asthma (author's transl)]. (1974) (0)
[Prostaglandins and pulmonary function. I. Effect of arachidonic acid on pulmonary function in healthy subjects and in patients with asthma]. (1977) (0)
[Proteolytic trypsin-like activity of the serum]. (1971) (0)
Inflammatory And Vasoactive Arachidonic Acid Metabolites In Patients With Obstructive Sleep Apnea (OSA) Treated With Mandibular Advancement Device (MAD) (2010) (0)
Serum proteolytic activity connected with 2 -macroglobulin in hemorrhagic diathesis. (1972) (0)
[Results of cholesterol assessment in a male population (author's transl)]. (1976) (0)
[Changes in eosinophil ultrastructure in Löffler's cardiomyopathy]. (1984) (0)
Abstract: P1155 PARAOXONASE 1 ACTIVITY, HOMOCYSTEINE AND CRP IN PATIENTS WITH ACUTE CORONARY SYNDROMES (2009) (0)
Role of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) derived prostaglandins (PG) in adaptive cytoprotection induced by mild stress (1998) (0)
[Utility of antropological methods in recognition of the Marfan syndrome]. (1972) (0)
[Hypersensitivity to insect venoms]. (1973) (0)
THE EFFECT OF SIX PROSTAGLANDINS, PROSTACYCLIN AND ILOPROST ON GENERATION OF SUPEROXIDE ANIONS (0J) BY HUMAN NEUTROPHILS (PMNs) ACTIVATED BY ZYMOSAN OR FMLP (1987) (0)
Exhaled Breath Condensate (EBC) Profile of Eicosanoids in Aspirin-Sensitive Astma. (2009) (0)
The late enzymatic test of myocardial infarction. (1969) (0)
[Pharmacotherapy of asthma and its prospects]. (1979) (0)
Discovery of the Defensive System of the Endothelium, the Lining of the Arterial Wall (2011) (0)
[Infarction of the right ventricle of the heart (description of 2 cases)]. (1969) (0)
[Differential diagnosis of hyperlipidemias and hypolipidemias in endocrinologic diseases]. (1974) (0)
[Effect of thromboxane A2 synthetase inhibitor and prostacyclin analogue on arterial blood pressure, fibrinolysis and platelet function in patients with hypertension]. (1991) (0)
[The methodological principles of the active prevention conducted within the framework of "the Polish trial" of the primary prevention of I.H.D (author's transl)]. (1976) (0)
Abstract 687: Increased Fibrin Clot Permeability and Susceptibility to Lysis as a Novel Antithrombotic Effect of Statins (2006) (0)
[Effect of troxerutin on bronchial spasm induced by inhalation of a specific allergen and on the neutrophil activity in patients with atopic bronchial asthma]. (1987) (0)
Exhaled eicosanoids following oral aspirin challenge in patients with asthma (2004) (0)
[Blood platelets and myocardial infarction]. (1984) (0)
[Myocarditis following smallpox vaccination]. (1965) (0)
[Prostaglandins and lung function. II. Bronchial reactivity to PGF 2-alpha and histamine in bronchial asthma]. (1979) (0)
Serum cobalt-activated acylase activity as a new enzymatic test in viral hepatitis. (1972) (0)
[Grade I heart block in hyperthyroidism]. (1971) (0)
[Diagnosis of perioperative myocardial infarction during coronary artery bypass surgery]. (1993) (0)
[Exercise test in the diagnosis of asthma in epidemiological studies]. (1974) (0)
3P-0859 The accuracy of D-dimer testing in patients with venous thromboembolism disease (2003) (0)
Molecule to and of a High Mobility Group-Related 315C - Gene: Binding of Sp1 to α RI ε the Fc 315C>T Polymorphism of - Discriminate the Two Different Transcription Factors (2013) (0)
Response (1994) (0)
[Asthma and aspirin intolerance]. (2000) (0)
[Prostacyclins and the development and treatment of arteriosclerosis]. (1980) (0)
[Treatment of hypertension in prevention of coronary heart disease (author's transl)]. (1976) (0)
Points: What about the bleeding time? (1985) (0)
[Enzymes conjugated with glutathione and their importance in medicine]. (2001) (0)
Fibrinolytic activity and response to t-PA in blacks and whites. (1991) (0)
Subject Index Vol. 77, 2009 (2008) (0)
CCR4-active chemokines contribute to blood and tissue eosinophilia in Churg–Strauss syndrome (2012) (0)
[Serum alpha-1-antitrypsin behavior in healthy subjects and in patients with pulmonary emphysema]. (1971) (0)
[Effect of cholinergic blockade with Atrovent on pulmonary function in people with asthma]. (1977) (0)
Prostaglandin E2 systemic production in asthma patients with and without aspirin hypersensitivity (2007) (0)
Discovery of the defensive system of endothelium (2012) (0)
Asthma Control And Determinants Of Poor Asthma Control In A Cohort Of Aspirin-sensitive Asthmatics (2010) (0)

This paper list is powered by the following services:

Other Resources About Andrzej Szczeklik

en.wikipedia.org

What Schools Are Affiliated With Andrzej Szczeklik?

Andrzej Szczeklik is affiliated with the following schools:

What Are Andrzej Szczeklik's Academic Contributions?

Andrzej Szczeklik is most known for their academic work in the field of philosophy. They are also known for their academic work in the fields of

Andrzej Szczeklik has made the following academic contributions:

Kore: On Sickness, the Sick, and the Search for the Soul of Medicine

Image Attributions

Image Source for Andrzej Szczeklik